Top Markets
#1 Black Phoenix Black Phoenix +1,205.99%
#2 HOPR HOPR +71.05%
#3 tomiNet tomiNet +68.26%
#4 Bedrock Bedrock +41.64%
#5 aPriori aPriori +36.11%
#6 OG Fan Token OG Fan Token +32.46%
#7 INFINIT INFINIT +29.91%
#8 哈基米 (Hakimi) 哈基米 (Hakimi) +29.35%
#9 ChainOpera AI ChainOpera AI +28.63%
#10 PUMPCADE PUMPCADE +28.03%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
AstraZeneca PLC AstraZeneca PLC

AstraZeneca PLC

AZN
Hisse Senetlerindeki Sıralama #105
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery,... AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Hisse Fiyatı
$193.62
Piyasa Değeri
$150.08B
Değişim (1 gün)
2.76%
Değişim (1 yıl)
184.69%
Ülke
GB
Ticaret AstraZeneca PLC (AZN)

Kategori

Healthcare
AstraZeneca PLC (AZN) için temettü geçmişi
AstraZeneca PLC (hisse sembolü: AZN) toplam 67 temettü ödemesi yaptı.
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $33.24
Temettü verimi (TTM): 0.0161
AstraZeneca PLC (AZN) için 1993 ile 2026 arasındaki temettü ödemeleri
Yıllık temettü ödemeleri
Yıl Temettü (hisse bölünmesiyle ayarlanmış) Değiştir
2026 (TTM) $2.17 38.88%
2025 $1.57 6.10%
2024 $1.48 1.72%
2023 $1.45 0.00%
2022 $1.45 3.57%
2021 $1.40 0.00%
2020 $1.40 0.00%
2019 $1.40 0.00%
2018 $1.40 0.00%
2017 $1.40 0.00%
2016 $1.40 0.00%
2015 $1.40 0.00%
2014 $1.40 0.00%
2013 $1.40 -1.75%
2012 $1.43 5.56%
2011 $1.35 12.03%
2010 $1.21 15.31%
2009 $1.05 10.00%
2008 $0.95 8.57%
2007 $0.875 24.11%
2006 $0.705 37.56%
2005 $0.5125 22.75%
2004 $0.4175 7.46%
2003 $0.3885 -0.13%
2002 $0.389 0.00%
2001 $0.389 -57.97%
2000 $0.9255 205.45%
1999 $0.303 -23.77%
1998 $0.3975 11.38%
1997 $0.3569 44.49%
1996 $0.247 -13.97%
1995 $0.2871 10.47%
1994 $0.2599 169.33%
1993 $0.0965 0.00%
Tüm temettü ödemelerinin listesi
Yıl Temettü Değiştir
2026 (TTM) $2.17 38.88%
2025 $1.57 6.10%
2024 $1.48 3.15%
2023 $1.43 0.70%
2022 $1.42 2.16%
2021 $1.39 0.00%
2020 $1.39 -0.71%
2019 $1.40 0.00%
2018 $1.40 0.00%
2017 $1.40 0.00%
2016 $1.40 -40.43%
2015 $2.35 -16.07%
2014 $2.80 0.00%
2013 $2.80 -1.75%
2012 $2.85 5.56%
2011 $2.70 12.03%
2010 $2.41 15.31%
2009 $2.09 10.00%
2008 $1.90 8.57%
2007 $1.75 24.11%
2006 $1.41 37.56%
2005 $1.03 22.75%
2004 $0.835 7.46%
2003 $0.777 -0.13%
2002 $0.778 0.00%
2001 $0.778 -57.97%
2000 $1.85 205.45%
1999 $0.606 -66.68%
1998 $1.82 -15.04%
1997 $2.14 44.47%
1996 $1.48 -13.99%
1995 $1.72 10.52%
1994 $1.56 169.26%
1993 $0.579 0.00%
Benzer şirketler veya rakipler için temettü ödemeleri
Şirket Temettü ödemesi sayısı Ülke
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
215.00%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
32.00%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US